A Multi-omic Association Study of Trimethylamine N-Oxide
Cell Reports, 2018
Manor O., Zubair N., Conomos M., Xu X., Rohwer J., Krafft C., Lovejoy J., Magis A.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
CVD | Pathophysiology | Plasma |  Olink Target 96 |
Abstract
Trimethylamine N-oxide (TMAO) is a circulating metabolite that has been implicated in the development of atherosclerosis and cardiovascular disease (CVD). In this paper, we identify blood markers, metabolites, proteins, gut microbiota patterns, and diets that are significantly associated with levels of plasma TMAO. We find that kidney markers are strongly associated with TMAO and identify CVD-related proteins that are positively correlated with TMAO.
We show that metabolites derived by the gut microbiota are strongly correlated with TMAO and that the magnitude of this correlation varies with kidney function. Moreover, we identify diet-associated patterns in the microbiome that are correlated with TMAO. These findings suggest that both the process of TMAO accumulation and the mechanism by which TMAO promotes atherosclerosis are a complex interplay between diet and the microbiome on one hand and other system-level factors such as circulating proteins, metabolites, and kidney function.
[Interesting to note that TMAO is considered to have causative roles in atherosclerosis and other CVDs, and while several plasma proteins correlated well with TMAO, traditional blood markers for CVD (e.g. cholesterol) show zero correlation]